title: Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL-apolipoprotein B particle and LDL-receptor in a subject with clinical homozygous familial hypercholesterolemia.
abstract: We identified a 38-yr-old male patient with the clinical expression of homozygous familial hypercholesterolemia presenting as severe coronary artery disease, tendon and skin xanthomas, arcus lipoides, and joint pain. The genetic trait seems to be autosomal recessive. Interestingly, serum concentrations of cholesterol responded well to diet and statins. We had no evidence of an abnormal low density lipoprotein (LDL)-apolipoprotein B (apoB) particle, which was isolated from the patient using the U937 proliferation assay as a functional test of the LDL-binding capacity. The apoB 3500 and apoB 3531 defects were ruled out by PCR. In addition, we found no evidence for a defect within the LDL-receptor by skin fibroblast analysis, linkage analysis, single-strand conformational polymorphism and Southern blot screening across the entire LDL-receptor gene. The in vivo kinetics of radioiodinated LDL-apoB were evaluated in the proband and three normal controls, subsequently. The LDL-apoB isolated from the patient showed a normal catabolism, confirming an intact LDL particle. In contrast the fractional catabolic rate (d-1) of autologous LDL in the subject and the normal controls revealed a remarkable delayed catabolism of the patient's LDL (0.15 vs. 0.33-0.43 d-1). In addition, the elevation of LDL-cholesterol in the patient resulted from an increased production rate with 22.8 mg/kg per day vs. 12.7-15.7 mg/kg per day. These data indicate that there is another catabolic defect beyond the apoB and LDL-receptor gene causing familial hypercholesterolemia.
authors.affiliation: Abteilung Gastroenterologie und Hepatologie, Medizinische Hochschule Hannover, Germany.
authors.forename: H H
authors.initials: HH
authors.lastname: Schmidt
authors.forename: M
authors.initials: M
authors.lastname: Stuhrmann
authors.forename: R
authors.initials: R
authors.lastname: Shamburek
authors.forename: C K
authors.initials: CK
authors.lastname: Schewe
authors.forename: M
authors.initials: M
authors.lastname: Ebhardt
authors.forename: L A
authors.initials: LA
authors.lastname: Zech
authors.forename: C
authors.initials: C
authors.lastname: Büttner
authors.forename: M
authors.initials: M
authors.lastname: Wendt
authors.forename: U
authors.initials: U
authors.lastname: Beisiegel
authors.forename: H B
authors.initials: HB
authors.lastname: Brewer
authors.forename: M P
authors.initials: MP
authors.lastname: Manns
mesh_terms: D000328:Adult; D001055:Apolipoproteins B / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood; D003327:Coronary Disease / Q000209:etiology; D005347:Fibroblasts / Q000378:metabolism; D005858:Germany; D006720:Homozygote; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000150:complications / Q000235:genetics*; D007457:Iodine Radioisotopes; D008077:Lipoproteins, LDL / Q000097:blood*; D008297:Male; D010375:Pedigree; D011973:Receptors, LDL / Q000378:metabolism*; D012867:Skin; D014421:Turkey / Q000208:ethnology; D014973:Xanthomatosis / Q000209:etiology
chemical_list: D001055:Apolipoproteins B; D008078:Cholesterol, LDL; D007457:Iodine Radioisotopes; D008077:Lipoproteins, LDL; D011973:Receptors, LDL